Vaccine and Clinical Trials

Vaccine for infectious illnesses in humans

About 25% of deaths globally are attributed to irreversible illnesses, especially in children younger than five. The establishment of appropriate mechanisms to ensure that all children get access to basic antibodies, regardless of geographic location or socioeconomic background, could significantly reduce the burden of incurable diseases. Additionally, new safe and effective vaccines should be developed for a variety of illnesses for which there is now no effective preventative intervention strategy available or practical. To ensure that these novel or enhanced antibodies are fully developed and made available to the underprivileged populations as quickly as possible, the public, commercial, and humanitarian sectors must work together.